Predictors of inhaled corticosteroid taper failure in adults with asthma

Affiliations

¹ Department of Medicine, University of South Florida, Tampa, Fla.
² Department of Medicine, Rush University Medical Center, Chicago, Ill.
³ Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pa.
⁴ Department of Pediatrics, Washington University, St Louis, Mo.
⁵ Department of Medicine, University of Arizona, Tucson, Ariz.
⁶ Department of Medicine, Washington University, St Louis, Mo.
⁷ Department of Medicine, National Jewish Health, Denver, Colo.
⁸ Department of Medicine, University of Pittsburgh, Pittsburgh, Pa.
⁹ Department of Medicine, Brigham and Women's Hospital, Boston, Mass.
¹⁰ Department of Medicine, Wake Forest University, Winston-Salem, NC.
¹¹ Department of Medicine, University of California-San Francisco, San Francisco, Calif.
¹² Department of Pediatrics, University of Wisconsin, Madison, Wis.
¹³ Department of Medicine, University of Illinois at Chicago, Chicago, Ill.
¹⁴ Department of Medicine, Brigham and Women's Hospital, Boston, Mass. Electronic address: eisrael@bwh.harvard.edu.

Juan Carlos Cardet et al. J Allergy Clin Immunol Pract. 2019 Apr.

. 2019 Apr;7(4):1335-1337.e3.

doi: 10.1016/j.jaip.2018.05.039. Epub 2018 Sep 19.

¹ Department of Medicine, University of South Florida, Tampa, Fla.
² Department of Medicine, Rush University Medical Center, Chicago, Ill.
³ Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pa.
⁴ Department of Pediatrics, Washington University, St Louis, Mo.
⁵ Department of Medicine, University of Arizona, Tucson, Ariz.
⁶ Department of Medicine, Washington University, St Louis, Mo.
⁷ Department of Medicine, National Jewish Health, Denver, Colo.
⁸ Department of Medicine, University of Pittsburgh, Pittsburgh, Pa.
⁹ Department of Medicine, Brigham and Women's Hospital, Boston, Mass.
¹⁰ Department of Medicine, Wake Forest University, Winston-Salem, NC.
¹¹ Department of Medicine, University of California-San Francisco, San Francisco, Calif.
¹² Department of Pediatrics, University of Wisconsin, Madison, Wis.
¹³ Department of Medicine, University of Illinois at Chicago, Chicago, Ill.
¹⁴ Department of Medicine, Brigham and Women's Hospital, Boston, Mass. Electronic address: eisrael@bwh.harvard.edu.

No abstract available

References

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2018. Available from: www.ginasthma.org. Accessed April 15, 2018.
1. Leuppi JD, Salome CM, Jenkins CR, Anderson SD, Xuan W, Marks GB, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001;163: 406–12. - PubMed
1. Foresi A, Mastropasqua B, Chetta A, D’Ippolito R, Testi R, Olivieri D, et al. Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma. Chest 2005;127:117–24. - PubMed
1. Tsurikisawa N, Tsuburai T, Oshikata C, Ono E, Saito H, Mitomi H, et al. Prognosis of adult asthma after normalization of bronchial hyperresponsiveness by inhaled corticosteroid therapy. J Asthma 2008;45:445–51. - PubMed
1. Deykin A, Lazarus SC, Fahy JV, Wechsler ME, Boushey HA, Chinchilli VM, et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 2005;115:720–7. - PubMed